Zobrazeno 1 - 10
of 53
pro vyhledávání: '"Alessandra, Pulvirenti"'
Autor:
Alessandra Pulvirenti, Marialuisa Barbagallo, Anna Rita Putignano, Antonio Pea, Rebecca Polidori, Rosie Upstill-Goddard, Nina Cortese, Paolo Kunderfranco, Laura Brunelli, Giulia De Simone, Roberta Pastorelli, Paola Spaggiari, Gennaro Nappo, Nigel B. Jamieson, Alessandro Zerbi, David K. Chang, Giovanni Capretti, Federica Marchesi
Publikováno v:
Frontiers in Oncology, Vol 14 (2024)
IntroductionMetabolic reprogramming is a hallmark feature of pancreatic ductal adenocarcinoma (PDAC). A pancreatic juice (PJ) metabolic signature has been reported to be prognostic of oncological outcome for PDAC. Integration of PJ profiling with tra
Externí odkaz:
https://doaj.org/article/a7368bd159a94ff69e5350a5c10d750f
Autor:
Louisa Bolm, MD, Martina Nebbia, MD, Alice C. Wei, MD, Amer H. Zureikat, MD, Carlos Fernández-del Castillo, MD, Jian Zheng, MD, Alessandra Pulvirenti, MD, Ammar A. Javed, MD, Yurie Sekigami, MD, Natalie Petruch, Motaz Qadan, MD, PhD, Keith D. Lillemoe, MD, Jin He, MD, Cristina R. Ferrone, MD, the Pancreatic Neuroendocrine Disease Alliance (PANDA)
Publikováno v:
Annals of Surgery Open, Vol 4, Iss 2, p e277 (2023)
Externí odkaz:
https://doaj.org/article/8e6751d51c704aae9a48f609c79ae263
Autor:
Louisa Bolm, MD, Martina Nebbia, MD, Alice C. Wei, MD, Amer H. Zureikat, MD, Carlos Fernández-del Castillo, MD, Jian Zheng, MD, Alessandra Pulvirenti, MD, Ammar A. Javed, MD, Yurie Sekigami, MD, Natalie Petruch, MD, Motaz Qadan, MD, PhD, Keith D. Lillemoe, MD, Jin He, MD, Cristina R. Ferrone, MD, the PAncreatic Neuroendocrine Disease Alliance (PANDA)
Publikováno v:
Annals of Surgery Open, Vol 4, Iss 1, p e245 (2023)
Externí odkaz:
https://doaj.org/article/9a8b37a9595145f3be2cd1fe113068f9
Autor:
Louisa, Bolm, Martina, Nebbia, Alice C, Wei, Amer H, Zureikat, Carlos, Fernández-Del Castillo, Jian, Zheng, Alessandra, Pulvirenti, Ammar A, Javed, Yurie, Sekigami, Natalie, Petruch, Motaz, Qadan, Keith D, Lillemoe, Jin, He, Cristina R, Ferrone
Publikováno v:
Annals of surgery. 276(3)
The role of parenchyma-sparing resections (PSR) and lymph node dissection in small (3 cm) nonfunctional pancreatic neuroendocrine tumors (PNET) is unlikely to be studied in a prospective randomized clinical trial. By combining data from 4 high-volume
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::ae203969a764b3a5249fe29538e9c47d
https://pubmed.ncbi.nlm.nih.gov/35758433
https://pubmed.ncbi.nlm.nih.gov/35758433
Autor:
David K. Chang, Roberto Salvia, Rosie Upstill-Goddard, Federica Marchesi, Alessandro Zerbi, Nigel B. Jamieson, Rita T. Lawlor, Stephan Dreyer, Anthony J. Gill, Jaswinder S. Samra, Euan J. Dickson, Andrew V. Biankin, Anubhav Mittal, Amber L. Johns, Aldo Scarpa, Georgios Gemenetzis, Kirsty Bisset, Fraser Duthie, Antonio Pea, Sarah Rae, Colin J. McKay, Alessandra Pulvirenti
Publikováno v:
Annals of Surgery. 277:e396-e405
Background: The long-term outcomes following surgical resection for pancreatic ductal adenocarcinoma (PDAC) remains poor, with only 20% of patients surviving 5 years after pancreatectomy. Patient selection for surgery remains sub-optimal largely due
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::55c1bdc0c3442237b17767719efbaf56
https://doi.org/10.1097/sla.0000000000005050
https://doi.org/10.1097/sla.0000000000005050
Publikováno v:
Frontiers in Medicine, Vol 7 (2020)
Well-differentiated pancreatic neuroendocrine tumors are increasingly diagnosed neoplasms. For localized disease, surgery is the first-line therapy and is curative in most cases. However, although recurrence is a rare event, it can still occur up to
Externí odkaz:
https://doaj.org/article/78f4093fee6c4e00a603deca7f84720c
Autor:
Ammar A, Javed, Alessandra, Pulvirenti, Samrah, Razi, Jian, Zheng, Theodoros, Michelakos, Yurie, Sekigami, Elizabeth, Thompson, David S, Klimstra, Vikram, Deshpande, Aatur D, Singhi, Matthew J, Weiss, Christopher L, Wolfgang, John L, Cameron, Alice C, Wei, Amer H, Zureikat, Cristina R, Ferrone, Jin, He
Publikováno v:
Annals of surgery.
To identify factors associated with concordance between World Health Organization (WHO) grade on cytological analysis (c-grade) and histopathological analysis (h-grade) of surgical specimen in patients with PanNETs and examine trends in utilization a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5d1a2a3499b668cb780203399f62dcd6
https://pubmed.ncbi.nlm.nih.gov/35081574
https://pubmed.ncbi.nlm.nih.gov/35081574
Autor:
Peter J. Allen, Abhishek Midya, Diane Lauren Reidy, Rikiya Yamashita, Alessandra Pulvirenti, Natally Horvat, Amber L. Simpson, Jayasree Chakraborty, Richard K. G. Do, Sharon A. Lawrence, David S. Klimstra, Maura A Koszalka, Mithat Gonen, Caitlin A. McIntyre, Kenneth Seier
Publikováno v:
JCO Clin Cancer Inform
PURPOSE The therapeutic management of pancreatic neuroendocrine tumors (PanNETs) is based on pathological tumor grade assessment. A noninvasive imaging method to grade tumors would facilitate treatment selection. This study evaluated the ability of q
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7da182b52684d4b26c67272f75ae9288
https://doi.org/10.1200/cci.20.00121
https://doi.org/10.1200/cci.20.00121
Autor:
Kevin C. Soares, Stefan Buettner, Alessandra Pulvirenti, Vicente Morales-Oyarvide, Matthew J. Weiss, Carsten Kamphues, Georgios Antonios Margonis, Katharina Beyer, Peter J. Allen, Jane Wang, Martin E. Kreis, John L. Cameron, Nikolaos Andreatos, Christopher L. Wolfgang, Carlos Fernandez-del Castillo
Publikováno v:
Annals of Surgery. 277:681-688
OBJECTIVE To validate the 7th and 8th editions of the American Joint Committee on Cancer (AJCC) staging system for patients with invasive carcinomas arising in association with IPMN (IPMN-associated PDAC). BACKGROUND DATA Although several studies hav
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2e4e6553bb129198928bd9bf4d462bfd
https://doi.org/10.1097/sla.0000000000005313
https://doi.org/10.1097/sla.0000000000005313
Autor:
Silvia Bozzarelli, Alessandra Pulvirenti, Francesca Gavazzi, Silvia Carrara, Jacopo Galvanin, Lorenza Rimassa, Damiano Gentile, Giovanni Capretti, Tommasangelo Petitti, Gennaro Nappo, Alessandro Zerbi, P. Spaggiari
Publikováno v:
Pancreatology. 21:950-956
Ampullary carcinoma (AC) is histologically classified as intestinal (In-AC), pancreaticobiliary (Pb-AC) or mixed-AC. The prognostic role of AC subtypes has been debated and remains unclear. The aims of this study were to evaluate outcomes after pancr
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8f4f4987a1a5ca58136e209d73d12cfb
https://doi.org/10.1016/j.pan.2021.03.005
https://doi.org/10.1016/j.pan.2021.03.005